Stockscreener 앱 받기
20.55
0.10%
0.02
Catalyst Pharmaceuticals Inc 주식(CPRX)의 최신 뉴스
What institutional flow reveals about Catalyst Pharmaceuticals Inc.Oil Prices & Free Risk Controlled Daily Trade Plans - newser.com
Is Catalyst Pharmaceuticals Inc. stock bottoming out2025 Pullback Review & Real-Time Volume Analysis Alerts - newser.com
Why hedge funds are buying Catalyst Pharmaceuticals Inc. stock2025 Volatility Report & Weekly Watchlist for Consistent Profits - Trung tâm Dự báo KTTV quốc gia
How Catalyst Pharmaceuticals Inc. stock benefits from strong dollarPortfolio Growth Summary & Capital Protection Trade Alerts - Trung tâm Dự báo KTTV quốc gia
How Catalyst Pharmaceuticals Inc. stock performs after earningsJuly 2025 Action & Reliable Entry Point Alerts - Trung tâm Dự báo KTTV quốc gia
Published on: 2025-10-17 22:48:25 - newser.com
First Week of June 2026 Options Trading For Catalyst Pharmaceuticals (CPRX) - Nasdaq
What macro factors could drive Catalyst Pharmaceuticals Inc. (CN2) stock higherWeekly Earnings Recap & High Win Rate Trade Alerts - newser.com
Why Catalyst Pharmaceuticals Inc. stock is favored by pension fundsWeekly Volume Report & Entry and Exit Point Strategies - newser.com
Using flow based indicators on Catalyst Pharmaceuticals Inc.July 2025 Market Mood & Advanced Technical Analysis Signals - newser.com
How to use Fibonacci retracement on Catalyst Pharmaceuticals Inc.Market Risk Summary & Daily Market Momentum Tracking - newser.com
Catalyst Pharmaceuticals Shares Climb as New Drug Developments Spark Fresh Valuation Debate - Yahoo Finance
Can Catalyst Pharmaceuticals Inc. (CN2) stock surprise with quarterly resultsBuy Signal & Weekly Breakout Opportunity Watchlist - newser.com
Catalyst Pharmaceuticals (CPRX): Assessing Valuation on Clinical Progress and Expanding Rare Disease Pipeline - Sahm
Assessing Catalyst Pharmaceuticals’ Value After Recent Positive FDA Ruling in 2025 - Sahm
Catalyst Pharmaceuticals Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Should Catalyst Pharmaceuticals’ (CPRX) Share Buyback and New Data Prompt a Fresh Look at Its Strategy? - Sahm
Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term - sharewise.com
Using Ichimoku Cloud for Catalyst Pharmaceuticals Inc. technicalsWatch List & Consistent Growth Equity Picks - newser.com
Published on: 2025-10-10 04:19:27 - newser.com
Will earnings trigger a reversal in Catalyst Pharmaceuticals Inc.Portfolio Return Summary & Fast Gaining Stock Strategy Reports - newser.com
Catalyst Pharmaceuticals (NASDAQ:CPRX) Earns "Hold (C+)" Rating from Weiss Ratings - MarketBeat
Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences - GlobeNewswire
Catalyst Pharmaceuticals to Present Research on Duchenne Muscular Dystrophy and Lambert Eaton Myasthenic Syndrome at Upcoming Scientific Conferences - Quiver Quantitative
3 Presentations: Catalyst Pharmaceuticals to present DMD & LEMS data at Oct 2025 conferences - Stock Titan
Real time breakdown of Catalyst Pharmaceuticals Inc. stock performance2025 Trading Volume Trends & Weekly High Potential Alerts - newser.com
Catalyst Pharmaceuticals Delivers Growth But Faces Narrow Pipeline Risk - Finimize
Published on: 2025-10-09 00:54:28 - newser.com
Lambert Eaton Myasthenic Syndrome Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Jacobus Pharmaceutical, Catalyst Pharmaceuticals - Barchart.com
Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term - Yahoo Finance
What do Analysts Think About Catalyst Pharmaceuticals (CPRX)? - Insider Monkey
Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Significant Upside Potential with 65% Growth Projection - DirectorsTalk Interviews
14 Biotech Stocks with High Potential - Insider Monkey
Will Catalyst Pharmaceuticals Inc. rebound enough to break evenTrade Risk Assessment & Daily Technical Forecast Reports - newser.com
Published on: 2025-10-06 05:08:49 - newser.com
Assessing Catalyst Pharmaceuticals (CPRX) Valuation After $200 Million Share Buyback Announcement - Yahoo Finance
Detecting price anomalies in Catalyst Pharmaceuticals Inc. with AIEarnings Summary Report & Long-Term Capital Growth Ideas - newser.com
A Closer Look at Catalyst Pharmaceuticals (CPRX) Valuation as Shares Remain Steady This Week - Sahm
Order flow analysis tools used on Catalyst Pharmaceuticals Inc.Weekly Trade Review & Capital Efficiency Focused Strategies - newser.com
Wealth Enhancement Advisory Services LLC Lowers Stock Position in Catalyst Pharmaceuticals, Inc. $CPRX - Defense World
Wall Street Zen Downgrades Catalyst Pharmaceuticals (NASDAQ:CPRX) to Hold - MarketBeat
Why Catalyst Pharmaceuticals Inc. (CN2) stock could break out in 2025July 2025 Weekly Recap & Stepwise Entry/Exit Trade Alerts - newser.com
Catalyst Pharmaceuticals Inc. stock daily chart insightsJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com
1.84%
0.50%
자본화:
|
볼륨(24시간):